0000902664-20-001237.txt : 20200219 0000902664-20-001237.hdr.sgml : 20200219 20200219144559 ACCESSION NUMBER: 0000902664-20-001237 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200214 FILED AS OF DATE: 20200219 DATE AS OF CHANGE: 20200219 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CLEMENS PETER J IV CENTRAL INDEX KEY: 0001199421 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-09974 FILM NUMBER: 20629042 MAIL ADDRESS: STREET 1: 2383 N. BERRY'S CHAPEL RD. CITY: FRANKLIN STATE: TN ZIP: 37069 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ENZO BIOCHEM INC CENTRAL INDEX KEY: 0000316253 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 132866202 STATE OF INCORPORATION: NY FISCAL YEAR END: 0731 BUSINESS ADDRESS: STREET 1: 60 EXECUTIVE BLVD CITY: FARMINGDALE STATE: NY ZIP: 11735 BUSINESS PHONE: 5167555500 MAIL ADDRESS: STREET 1: ENZO BIOCHEM INC STREET 2: 60 EXECUTIVE BLVD CITY: FARMINGDALE STATE: NY ZIP: 11735 4 1 ownership.xml X0306 4 2020-02-14 0 0000316253 ENZO BIOCHEM INC ENZ 0001199421 CLEMENS PETER J IV 2383 N. BERRY'S CHAPEL RD. FRANKLIN TN 37069 0 0 1 0 Common Stock, $0.01 par value ("Common Stock") 2020-02-14 4 P 0 6000 2.21 A 11000 D Common Stock 2020-02-18 4 P 0 4000 2.20 A 15000 D This Form 4 is filed by Peter J. Clemens, IV (the "Reporting Person"). The Reporting Person may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding common stock. The Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of his pecuniary interest therein. /s/ Peter J. Clemens, IV 2020-02-19